Cocrystal Pharma Announces Closing of $6.8 Million Registered Direct Offering Priced At-the-Market
March 11, 2020 09:40 ET
|
Cocrystal Pharma, Inc.
BOTHELL, WA, March 11, 2020 (GLOBE NEWSWIRE) -- COCRYSTAL PHARMA, INC. (NASDAQ: COCP) (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel...